drugset / Trial / NCT05211050
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
RandomizedCrossoverQuadruple-blindOther
Summary
The study aims to explore the effects of Sumatriptan on Levcromakalim-induced migraine in individuals with migraine without aura.
Timeline
- Start
- 2022-03-15
- Primary completion
- 2023-11-05
- Completion
- 2023-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sumatriptan | Unknown | 4 mg | — |
| Comparator | Levcromakalim | Small molecule | 1 mg | Intravenous |